يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Jonathan P. Blatchford"', وقت الاستعلام: 1.65s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المساهمون: Saint Luke's Mid America Heart Institute, University of Missouri [Kansas City] (UMKC), University of Missouri System, University of New South Wales [Sydney] (UNSW), University Hospital of Würzburg, University of Würzburg = Universität Würzburg, Vanderbilt University Medical Center [Nashville], Vanderbilt University [Nashville], University of California [San Francisco] (UC San Francisco), University of California (UC), Veterans Affairs Medical Center, San Francisco, California, University of Wrocław [Poland] (UWr), Institut d'Investigació Biomèdica de Bellvitge [Barcelone] (IDIBELL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Faculdade de Medicina da Universidade do Porto (FMUP), Universidade do Porto = University of Porto, Duke University Medical Center, Inova Heart and Vascular Institute, Saw Swee Hock School of Public Health [Singapore, Singapore], National University of Singapore (NUS), Boehringer Ingelheim International GmbH, Elderbrook Solutions GmbH on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, University Medical Center Groningen [Groningen] (UMCG), The EMPULSE (EMPagliflozin in patients hospitalized with acUte heart faiLure who have been StabilizEd) trial was funded by the Boehringer Ingelheim and Eli Lilly and Company DiabetesAlliance, BOZEC, Erwan, Cardiovascular Centre (CVC)

    المصدر: Circulation
    Circulation, 2022, ⟨10.1161/CIRCULATIONAHA.122.059725⟩
    Dipòsit Digital de la UB
    Universidad de Barcelona
    Circulation, 146(4), 279-288. LIPPINCOTT WILLIAMS & WILKINS

    وصف الملف: application/pdf

  4. 4

    المساهمون: Cardiovascular Centre (CVC)

    المصدر: Nature Medicine, 28(3), 568-574. Nature Publishing Group
    Voors, A A, Angermann, C E, Teerlink, J R, Collins, S P, Kosiborod, M, Biegus, J, Ferreira, J P, Nassif, M E, Psotka, M A, Tromp, J, Borleffs, C J W, Ma, C, Comin-Colet, J, Fu, M, Janssens, S P, Kiss, R G, Mentz, R J, Sakata, Y, Schirmer, H, Schou, M, Schulze, P C, Spinarova, L, Volterrani, M, Wranicz, J K, Zeymer, U, Zieroth, S, Brueckmann, M, Blatchford, J P, Salsali, A & Ponikowski, P 2022, ' The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure : a multinational randomized trial ', Nature Medicine, vol. 28, no. 3, pp. 568-574 . https://doi.org/10.1038/s41591-021-01659-1Test

    وصف الملف: application/pdf